Crestline Management, LP Liquidia Corp Transaction History
Crestline Management, LP
- $2.93 Billion
- Q4 2024
A detailed history of Crestline Management, LP transactions in Liquidia Corp stock. As of the latest transaction made, Crestline Management, LP holds 83,305 shares of LQDA stock, worth $1.34 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
83,305
Previous 49,059
69.81%
Holding current value
$1.34 Million
Previous $490,000
99.8%
% of portfolio
0.03%
Previous 0.03%
Shares
2 transactions
Others Institutions Holding LQDA
# of Institutions
188Shares Held
44.8MCall Options Held
1.22MPut Options Held
1.09M-
Black Rock Inc. New York, NY4.24MShares$68.3 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.56MShares$57.3 Million0.0% of portfolio
-
Farallon Capital Management LLC San Francisco, CA3.29MShares$53 Million0.21% of portfolio
-
Findell Capital Management LLC New York, NY3.08MShares$49.6 Million14.82% of portfolio
-
Kynam Capital Management, LP Princeton, NJ2.27MShares$36.5 Million1.69% of portfolio
About Liquidia Corp
- Ticker LQDA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 64,362,300
- Market Cap $1.04B
- Description
- Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension. It also distributes generic treprostinil inje...